CAV1 and chronic granulomatous disease: When compared to the same vector administered via i.v. infusion, AAV2/8CAV1 i.p. injection leads to greater CAV1 expression levels in the gallbladder and lower CGD incidence in LD-fed mice via reduction of gallbladder MUC1 expression and enhancement of gallbladder motility.